Cargando…
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substan...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870365/ https://www.ncbi.nlm.nih.gov/pubmed/29547576 http://dx.doi.org/10.3390/brainsci8030047 |
_version_ | 1783309466171604992 |
---|---|
author | Martinotti, Giovanni Santacroce, Rita Pettorruso, Mauro Montemitro, Chiara Spano, Maria Chiara Lorusso, Marco di Giannantonio, Massimo Lerner, Arturo G. |
author_facet | Martinotti, Giovanni Santacroce, Rita Pettorruso, Mauro Montemitro, Chiara Spano, Maria Chiara Lorusso, Marco di Giannantonio, Massimo Lerner, Arturo G. |
author_sort | Martinotti, Giovanni |
collection | PubMed |
description | Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substance misuse, but it can arise in anyone, even after a single exposure to triggering drugs. The aims of the present study are to review all the original studies about HPPD in order to evaluate the following: (1) the possible suggested etiologies; (2) the possible hallucinogens involved in HPPD induction; (3) the clinical features of both HPPD I and II; (4) the possible psychiatric comorbidities; and (5) the available and potential therapeutic strategies. We searched PubMed to identify original studies about psychedelics and Hallucinogen Persisting Perception Disorder (HPPD). Our research yielded a total of 45 papers, which have been analyzed and tabled to provide readers with the most updated and comprehensive literature review about the clinical features and treatment options for HPPD. |
format | Online Article Text |
id | pubmed-5870365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58703652018-03-27 Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives Martinotti, Giovanni Santacroce, Rita Pettorruso, Mauro Montemitro, Chiara Spano, Maria Chiara Lorusso, Marco di Giannantonio, Massimo Lerner, Arturo G. Brain Sci Review Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly understood condition linked to hallucinogenic drugs consumption. The prevalence of this disorder is low; the condition is more often diagnosed in individuals with a history of previous psychological issues or substance misuse, but it can arise in anyone, even after a single exposure to triggering drugs. The aims of the present study are to review all the original studies about HPPD in order to evaluate the following: (1) the possible suggested etiologies; (2) the possible hallucinogens involved in HPPD induction; (3) the clinical features of both HPPD I and II; (4) the possible psychiatric comorbidities; and (5) the available and potential therapeutic strategies. We searched PubMed to identify original studies about psychedelics and Hallucinogen Persisting Perception Disorder (HPPD). Our research yielded a total of 45 papers, which have been analyzed and tabled to provide readers with the most updated and comprehensive literature review about the clinical features and treatment options for HPPD. MDPI 2018-03-16 /pmc/articles/PMC5870365/ /pubmed/29547576 http://dx.doi.org/10.3390/brainsci8030047 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Martinotti, Giovanni Santacroce, Rita Pettorruso, Mauro Montemitro, Chiara Spano, Maria Chiara Lorusso, Marco di Giannantonio, Massimo Lerner, Arturo G. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title_full | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title_fullStr | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title_full_unstemmed | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title_short | Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives |
title_sort | hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870365/ https://www.ncbi.nlm.nih.gov/pubmed/29547576 http://dx.doi.org/10.3390/brainsci8030047 |
work_keys_str_mv | AT martinottigiovanni hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT santacrocerita hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT pettorrusomauro hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT montemitrochiara hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT spanomariachiara hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT lorussomarco hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT digiannantoniomassimo hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives AT lernerarturog hallucinogenpersistingperceptiondisorderetiologyclinicalfeaturesandtherapeuticperspectives |